Full Breakdown
Recall of Alcohol Prep Pads Due to Microbial Contamination
3/22/2026, 11:22:11 AM
Overview of the Recall
The Food and Drug Administration (FDA) has announced a voluntary recall of specific lots of Webcol Large Alcohol Prep Pads, produced by Cardinal Health, due to potential microbial contamination. The recall was initiated on March 2, 2026, after it was determined that the pads may be contaminated with the bacteria Paenibacillus phoenicis, which poses significant health risks, particularly to immunocompromised individuals.
Health Risks Associated with Contamination
The contamination of these alcohol prep pads is particularly concerning for at-risk populations, including patients undergoing chemotherapy or those with poorly controlled diabetes. The presence of Paenibacillus phoenicis can lead to serious infections, including local and systemic infections, and may result in life-threatening conditions or central nervous system infections.
Distribution and Identification of Affected Products
The affected alcohol prep pads were distributed across the United States, Puerto Rico, and Japan between September 2025 and February 2026. Consumers can identify the recalled products by specific lot numbers, which have been provided in the recall notice.
Cardinal Health's Response
In response to the recall, Cardinal Health has urged customers to take immediate action. They recommend that consumers review their inventory for the affected product codes, separate and quarantine any identified products, and disseminate the recall notice to all relevant departments and clinics. Additionally, customers are instructed to notify any recipients of the affected products and return an acknowledgment form to confirm receipt of the recall notice.
Criticism & Opposition
While the recall aims to protect public health, some critics have raised concerns about the adequacy of quality control measures at Cardinal Health. Questions have been raised regarding how such contamination could occur and what steps will be taken to prevent future incidents.
Official Statements & Responses
Cardinal Health has stated, “We are committed to ensuring the safety and quality of our products and are taking this matter seriously.” The FDA has also emphasized the importance of consumer vigilance in monitoring for affected products and following the recall instructions.
What's Next
As the recall progresses, Cardinal Health is expected to provide further updates on the investigation into the contamination and any additional measures that may be implemented to enhance product safety. Consumers are advised to stay informed about the recall and adhere to the guidelines provided by Cardinal Health and the FDA.
